Cargando…

Pro re nata prescribing and administration for neuropsychiatric symptoms and pain in long-term care residents with dementia and memory problems: a cross-sectional study

Background Prescribing, dispensing and administering pro re nata (PRN; as needed or necessary, as determined by an individual) medicines to people with intermittent or short-term conditions is a potential area for medication errors and inappropriate prescribing and administration. In people with dem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Griffiths, Alys W., Surr, Claire A., Alldred, David P., Baker, John, Higham, Ruchi, Spilsbury, Karen, Thompson, Carl A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800850/ https://www.ncbi.nlm.nih.gov/pubmed/31342248 http://dx.doi.org/10.1007/s11096-019-00883-7

Ejemplares similares

Patient Safety and Pro Re Nata Prescription and Administration: A Systematic Review
por: Vaismoradi, Mojtaba, et al.
Publicado: (2018)

Pro Re Nata Use of Psychotropic Medications in Assisted Living
por: Carder, Paula, et al.
Publicado: (2020)

Pro Re Nata Prescription and Perception Difference between Doctors and Nurses
por: Oh, Se Hwa, et al.
Publicado: (2014)

Initial Pro Re Nata Brolucizumab for Exudative AMD: The PROBE Study
por: Bilgic, Alper, et al.
Publicado: (2021)

Influence of Psychotropic Pro Re Nata Drug Use on Outcomes in Hospitalized Patients with Schizophrenia
por: Kyou, Yoshitaka, et al.
Publicado: (2023)

Implementing Dementia Care Mapping as a practice development tool in dementia care services: a systematic review
por: Surr, Claire A, et al.
Publicado: (2018)

Does accreditation improve pro re nata benzodiazepines administration in psychiatric inpatients? Pre-post accreditation medical record comparison
por: Al-Sughayir, Mohammed Abdullah
Publicado: (2017)

The use and effectiveness of pro re nata psychotropic medications in children and adolescents: A systematic review
por: Asogwa, Kenneth, et al.
Publicado: (2017)

A biopsychosocial interpretation of the Neuropsychiatric Inventory – Nursing Home assessment: reconceptualising psychiatric symptom attributions
por: Smith, Sarah J., et al.
Publicado: (2020)

Potentially Inappropriate Medication Use among Nursing Home Residents: Medication Errors Associated with Pro re nata Medications and the Importance of Pill Burden
por: Koçak, Fatma Özge Kayhan, et al.
Publicado: (2022)

The monitoring and use of Pro re nata (PRN) psychotropic medication for people with learning disabilities on an inpatient ward
por: Mistry, Heena
Publicado: (2021)

Efficacy and safety of Pro Re Nata regimen without loading dose ranibizumab injections in retinal vein occlusion
por: Unsal, Erkan, et al.
Publicado: (2015)

Anti-VEGF injection frequency correlates with visual acuity outcomes in pro re nata neovascular AMD treatment
por: Wecker, Thomas, et al.
Publicado: (2019)

Factors associated with extended remission in neovascular age-related macular degeneration on pro re nata treatment protocol
por: Lin, Tiezhu, et al.
Publicado: (2020)

Audit on use of PRN (pro re nata) psychotropic medication for behavioural disturbance in individuals with intellectual disability in the community
por: Dhandapani, Asha, et al.
Publicado: (2021)

Staff experiences of implementing Dementia Care Mapping to improve the quality of dementia care in care homes: a qualitative process evaluation
por: Griffiths, Alys Wyn, et al.
Publicado: (2021)

Two-year outcomes of pro re nata ranibizumab monotherapy for exudative age-related macular degeneration in Japanese patients
por: Yamamoto, Akiko, et al.
Publicado: (2013)

Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema
por: Rishi, Pukhraj, et al.
Publicado: (2020)

Older Adults Living in Sheltered Housing’s Experiences of Involvement in Pro Re Nata Decisions. A Narrative Positioning Analysis
por: Nilsen, Marianne Kollerøs, et al.
Publicado: (2021)

Use of Psychotropic “Pro Re Nata” Medications by Patients Attending the Outpatient Clinic in a Hospital: A Qualitative Exploration
por: Rajiah, Kingston, et al.
Publicado: (2021)

The Impact of Interval between Recurrence and Reinjection in Anti-VEGF Therapy for Diabetic Macular Edema in Pro Re Nata Regimen
por: Takamura, Yoshihiro, et al.
Publicado: (2021)

A Randomized, Controlled Trial of Treat-and-Extend vs. Pro Re Nata Regimen for Neovascular Age-Related Macular Degeneration
por: Jia, Huixun, et al.
Publicado: (2022)

Intravitreal injection of ranibizumab using a pro re nata regimen for age-related macular degeneration and vision-related quality of life
por: Inoue, Maiko, et al.
Publicado: (2014)

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
por: Wecker, Thomas, et al.
Publicado: (2017)

Treat-and-Extend vs. Pro Re Nata Regimen of Ranibizumab for Diabetic Macular Edema—A Two-Year Matched Comparative Study
por: Lai, Tso-Ting, et al.
Publicado: (2022)

Pro re nata versus fixed aflibercept regimen for neovascular age-related macular degeneration: a systematic review and meta-analysis
por: Victor, Andi Arus, et al.
Publicado: (2022)

Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes
por: Griffiths, Alys W., et al.
Publicado: (2019)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
por: Narayanan, Raja, et al.
Publicado: (2016)

MANAGEMENT OF NONCOGNITIVE NEUROPSYCHIATRIC SYMPTOMS OF DEMENTIA IN NURSING HOME RESIDENTS
por: Basnet, Prasanna, et al.
Publicado: (2019)

Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen
por: Miere, Alexandra, et al.
Publicado: (2018)

Ten-year real-world outcomes of antivascular endothelial growth factor therapy in neovascular age-related macular degeneration using pro re nata regimen
por: Hujanen, Pekko, et al.
Publicado: (2023)

Navigating cancer treatment and care when living with comorbid dementia: an ethnographic study
por: Surr, Claire, et al.
Publicado: (2020)

Complexities of trial recruitment in the care home setting: an illustration via the DCM™epic (dementia care mapping™: to enable person-centred care in care homes) trial
por: Surr, Claire, et al.
Publicado: (2015)

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab
por: Elwes, Flora, et al.
Publicado: (2018)

FACTOR STRUCTURE OF NEUROPSYCHIATRIC SYMPTOM FREQUENCY IN HOME-RESIDING PERSONS WITH DEMENTIA
por: Hodgson, Nancy, et al.
Publicado: (2019)

Enabling people with dementia to access and receive cancer treatment and care: The crucial role of supportive networks
por: Surr, Claire A., et al.
Publicado: (2020)

Balancing the needs of individuals and services in cancer treatment for people with dementia: A focused ethnographic study
por: Griffiths, Alys Wyn, et al.
Publicado: (2021)

‘To give or not to give medication, that is the question.’ Healthcare personnel’s perceptions of factors affecting pro re nata medication in sheltered housing for older adults — a focus-group interview study
por: Nilsen, Marianne Kollerøs, et al.
Publicado: (2020)

Barriers and facilitators to implementing dementia care mapping in care homes: results from the DCM™ EPIC trial process evaluation
por: Griffiths, Alys W., et al.
Publicado: (2019)

Abstracts of the 2022 48th Annual NATAS Conference
por: Adams, Tina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mbdbbb86n030voojlr0fpqsmq9